Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase

Journal of Medicinal Chemistry

Volumn 40, Issue 20, 1997, Pages 3228-3233

  Rhee, Man Hee ^a   Vogel, Zvi ^a   Barg, Jacob ^a   Bayewitch, Michael ^a   Levy, Rivka ^a   Hanuš, Lumir ^b   Breuer, Aviva ^b   Mechoulam, Raphael ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIMETHYLHEPTYL 11 HYDROXYCANNABINOL; 11 HYDROXYCANNABINOL; ADENYLATE CYCLASE; CANNABINOID RECEPTOR; CANNABINOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN SYNAPTOSOME; CHO CELL; DRUG RECEPTOR BINDING; ENZYME INHIBITION; KIDNEY CELL; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ADENYLATE CYCLASE; ANIMALS; BRAIN; CANNABINOIDS; CANNABINOL; CATALEPSY; CHO CELLS; COS CELLS; CRICETINAE; ENZYME INHIBITORS; HUMANS; KINETICS; MICE; MODELS, CHEMICAL; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTOSOMES; TRANSFECTION;

EID: 0030756533     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970126f     Document Type: Article

References (36)

1. Pertwee, R., Ed. Cannabinoid Receptors; Harcourt Brace & Co.: London, 1995.
2. Howlett, A. C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 607-634. Piomelli, D. Arachidonic Acid in Cell Signalling; R. G. Landes Co.: Austin, TX, 1996.
3. Howlett, A. C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 607-634. Piomelli, D. Arachidonic Acid in Cell Signalling; R. G. Landes Co.: Austin, TX, 1996.
4. Herkenham, M. Localization of cannabinoid receptors in brain and periphery. In Cannabinoid Receptors; Pertwee, R., Ed.; Harcourt Brace & Co.: London, 1995; pp 145-166.
5. Galiegue, S.; Mary, S.; Marchand, J.; Dussossoy, D.; Carriere, D.; Carayon, P.; Bouaboula, M.; Shire, D.; Lefur, G.; Casellas, P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 1995, 232, 55-61.
6. Mechoulam, R.; Devane, W. A.; Glaser, R. Cannabinoid geometry and biological activity. In Marijuana/Cannabinoids: Neurobiology and Neurophysiology; Murphy, L., Bartke, A., Eds.; CRC Press: Boca Raton, FL, 1992; pp 1-33.
7. Martin, B. R.; Thomas, B. F.; Razdan, R. K. Structural requirements for cannabinoid receptor probes. In Cannabinoid Receptors; Pertwee, R., Ed.; Harcourt Brace & Co.: London, 1995; pp 36-85.
8. Melvin, L. S.; Milne, G. M.; Ross Johnson, M.; Wilken, G. H.; Howlett, A. C. Structure-activity relationships defining the ACD- tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity. Drug Des. Discov. 1995, 13, 155-166.
9. (a) Gareau, Y.; Dufresne, C.; Gallant, M.; Rochette, C.; Sawyer, N.; Slipetz, D. M.; Tremblay, N.; Weech, P. K.; Metters, K. M.; Labelle, M. Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors. Bioorg. Med. Chem. Lett. 1996, 6, 189-194.
10. (b) Showalter, V. M.; Compton, D. R.; Martin, B. R.; Abood, E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther. 1996, 278, 989-999.
11. Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61-65.
12. Razdan, R. K. Structure-activity relationships in cannabinoids. Pharmacol. Rev. 1986, 38, 75-149.
13. Bayewitch, M.; Avidor-Reiss, T.; Levy, R.; Barg, J.; Mechoulam, R.; Vogel, Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett. 1995, 275, 143-147.
14. 9-Tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylylcyclase. J. Biol. Chem. 1996, 271, 9902-9905.
15. Mechoulam, R.; Ben-Shabat, S.; Hanuš, L; Ligumsky, M.; Kaminski, N. E.; Schatz, A. R.; Gopher, A.; Almog, S.; Martin, B. R.; Compton, D. R.; Pertwee, R. G.; Griffin, G.; Bayewitch, M.; Barg, J.; Vogel, Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 1995, 50, 83-90.
16. Devane, W. A.; Hanuš, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946- 1949. Hanuš, L.; Gopher, A.; Almog, S.; Mechoulam, R. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J. Med. Chem. 1993, 3032-3034.
17. Devane, W. A.; Hanuš, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946- 1949. Hanuš, L.; Gopher, A.; Almog, S.; Mechoulam, R. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J. Med. Chem. 1993, 3032-3034.
18. Gaoni, Y.; Mechoulam, R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 1964, 86, 1646.
19. 1-THC and other neutral cannabinoids from hashish. J. Am. Chem. Soc. 1971, 93, 217-224.
20. Baek, S.-H.; Srebnik, M.; Mechoulam, R. Boron trifluoride etherate on alimina - A modified Lewis acid reagent. An improved synthesis of cannabidiol. Tetrahedron Lett. 1985, 26, 1083-1086.
21. Loev, B. Dibenzo[b,d]pyran compounds. U.S. Patent 3,799,946, 1974.
22. 1(6)- THC metabolites. Tetrahedron Lett. 1970, 4495-4497.
23. Mechoulam, R.; Lander, N.; Breuer, A.; Zahalka, J. Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivative. Tetrahedron: Asymmetry 1990, 1, 315-319.
24. 6-THC metabolite: isolation and synthesis. Experientia 1973, 29, 1193-1195.
25. 1-tetrahydrocannabinol and cannabidiol. Biomed. Mass Spectrom. 1977, 4, 364-369.
26. Burstein, S. H.; Audette, C. A.; Breuer, A.; Devane, W. A.; Colodner, S.; Doyle, S. A.; Mechoulam, R. Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic and leukocyte antiadhesion activities. J. Med. Chem. 1992, 35, 3135- 3141.
27. (a) Adams, R.; Baker, B. R. Structure of cannabinol. A second method of synthesis of cannabinol. J. Am. Chem. Soc. 1940, 62, 2401.
28. (b) Ghosh, R.; Todd, A. R.; Wilkinson, S. The synthesis of cannabinol. J. Chem. Soc. 1940, 1393.
29. (c) Adams, R.; Mackenzie, S., Jr.; Loewe, S. Tetrahydrocannabinol homologs with doubly branched alkyl groups in the 3-position. J. Am. Chem. Soc. 1948, 70, 664.
30. (d) For a review, see: Mechoulam, R. Cannabinoid Chemistry. In Marijuana, Chemistry, Pharmacology, Metabolism and Clinical Effects; Mechoulam, R., Ed.; Academic Press: New York, 1973; pp 1-99.
31. Matsuda, L. A.; Lolait, S. J.; Brownstein, M. J.; Young, A. C.; Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346, 561-564.
32. Devane, W. A.; Breuer, A.; Sheskin, T.; Järbe, T. U. C.; Eisen, M.; Mechoulam, R. A novel probe for the cannabinoid receptor. J. Med. Chem. 1992, 35, 2065-2069.
33. Vogel, Z.; Barg, J.; Levy, R.; Saya, D.; Heldman, E.; Mechoulam, R. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 1993, 61, 352-355.
34. 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev. 1986, 38, 1, 21-43.
35. Levitzki, A. Receptors. A Quantitative Approach; The Benjamin/ Cummings Publishing Co.: Menlo Park, CA, 1984; pp 19-36.
36. DeLean, A.; Munson, P. J.; Rodbard, D. A User's Guide to ALLFIT; National Institutes of Health: Bethesda, MD; pp 97-102.